Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;48(100):44-54.
doi: 10.1016/j.futures.2013.02.002.

Frames and comparators: How might a debate on synthetic biology evolve?

Affiliations

Frames and comparators: How might a debate on synthetic biology evolve?

Helge Torgersen et al. Futures. 2013 Apr.

Abstract

A stimulated early public debate is frequently advocated when introducing an emerging technology like synthetic biology (SB). To debate a still quite abstract technology, participants functionally need a frame that determines which arguments are legitimate and which issues are relevant. Often, such frames are based on previous debates over other novel technologies. Three technologies currently provide frames for discussing SB: (green) biotechnology, nanotechnology and information technology. In the biotechnology debate, risk has long been emphasised over economic benefits. More recently, nanotechnology has been referred to mostly in terms of benefits, while risks tended to be an issue for scientific discourses. This has frequently been related to the many outreach activities around nanotechnology. Information technology, finally, has retained the image of being 'cool' and useful on a personal level. The technology itself is taken for granted and only the consequences of particular applications have been up for discussion. Upstream engagement exercises in SB will have to consider the comparator chosen more diligently, because it might influence the debate on SB 'out there' in the long run.

PubMed Disclaimer

References

    1. G. Gaskell, et al., Europeans and Biotechnology in 2010: Winds of Change? A Report to the European Commission's Directorate-General for Research on the Eurobarometer 73.1 on Biotechnology, FP7 Project ‘Sensitive Technologies and European Public Ethics’ (STEPE), London School of Economics, London, 2010.
    1. Schmidt M., Ganguli-Mitra A., Torgersen H., Kelle A., Deplazes A., Biller-Andorno N. A priority paper for the societal and ethical aspects of synthetic biology. Systems and Synthetic Biology. 2009;3:3–7. - PMC - PubMed
    1. Nelkin D., editor. Controversy – Politics of Technical Decisions. Sage; Newbury Park: 1984.
    1. Gaskell G., Bauer M., editors. Biotechnology 1996-2000. The Years of Controversy. Science Museum Press; London: 2002.
    1. Evans J.H. University of Chicago Press; Chicago: 2002. Playing God? Human Genetic Engineering and the Rationalization of Public Bioethical Debate. - PubMed

LinkOut - more resources